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ND license.1. Introduction
Imidazole[2,1-b][1,3,4]thiadiazole derivatives have been of
interest to the medicinal chemists for many years because of
their anticancer (Terzioglu and Gursoy, 2003), antitubercular
(Gadad et al., 2004), antibacterial (Gadad et al., 2000; Mohan
and Varman, 1999),antifungal (Andotra et al., 1997), anticon-
vulsant, analgesic(Khazi et al., 1996) and antisecretory
(Andreani et al., 2000) activities. This is due to the fact that
the imidazole [2,1-b][1,3,4] thiadiazole system is similar in part
to Levamisole, a well-known immune modulator (Amery et al.,
1984; Renoux and Renoux, 1974). Moreover Mannich bases of
many heterocycles are known for diverse biological activities
(Kumar, 2010). The authors have recently reported that
Mannich bases of imidazole [2,1-b][1,3,4] thiadiazoles possess
considerable antitubercular and antimicrobial activities
212 A. Banu et al.(Hegde et al., 2006). One such Mannich reaction is discussed
here.
Apart from this, ﬂuorinated compounds in general and
ﬂuorinated heterocyclic compounds in particular, are the focus
of much interest in modern medicinal chemistry. In other clas-
ses of antitumour compounds, e.g. the anthracycline antibiot-
ics (Miller and Stoodley, 2010), the substitution of a hydrogen
atom for a ﬂuorine atom in the tetracyclic ring system was
found to possess better antitumour properties (Animati
et al., 1996). In recent years there have been reports that the
incorporation of ﬂuorine atom could alter the course of the
reaction as well as enhance the biological properties. Accumu-
lation of ﬂuorine on carbon leads to increased oxidative and
thermal stabilities. Thus ﬂuorinated drugs, being metabolically
non-degradable, are regarded as useful therapeutic agents.
Further, such drugs have increased lipid solubility, resulting
in an increased rate of absorption and transport in vivo
(Strunecka et al., 2004; Kevin Park et al., 2001). In view of
the above facts and in continuation of our search for various
biologically active molecules (Kolavi et al., 2006a, b; Hegde
et al., 2006), we report herein the structural studies on 2-(4-ﬂu-
orobenzyl)-6-(4-methoxyphenyl)imidazo[2,1-b][1,3,4] thiadia-
zole and its morpholinomethyl derivative.
The syntheses of these compounds were followed by mea-
surement of their analytical data and subsequent spectroscopic
analyses using IR and 1H NMR techniques to conﬁrm the
presence of the supposed ring systems, the presence of ﬂuoro
and methoxy substituent as well as the signals for the existence
of various protons.
The two compounds were subjected to single crystal X-ray
diffraction analyses so that their supramolecular structures
could be investigated in terms of possible intermolecular
interactions.2. Experimental
2.1. Materials
All reagents were obtained from commercial sources. Solvents
were dried and puriﬁed with known conventional methods.S
NN
NH2
F
Br
O
MeO
+
1
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Scheme 1 Syntheses of2.2. Analytical methods
The melting points were determined in open capillaries and are
uncorrected. The IR spectra were recorded as KBr discs using
a Nicolet FT-IR 410 spectrophotometer. 1H NMR spectra
were recorded on a Varian RXZ-300 MHz spectrometer using
TMS as internal reference compound. C, H and N were esti-
mated on a Heraus CHN rapid analyzer at Karnatak Univer-
sity, Dharwad, India. The title compound was prepared in two
stages as shown in Scheme 1.
2.3. Procedure for the preparation of 2-(4-ﬂuorobenzyl)-6-(4-
methoxyphenyl)imidazo[2,1-b][1,3,4] thiadiazole (2) and its
morpholinomethyl derivative (3)
A mixture of 5-(4-ﬂuorobenzyl)-1,3,4-thiadiazol-2-amine (1)
(Eberle et al., 1972) (2.69 g, 0.01 mol) and p-methoxy phenacyl
bromide (0.01 mol) was reﬂuxed in dry ethanol for 12 h. The
excess of solvent was distilled off and the solid hydrobromide
salt that separated was collected by ﬁltration, suspended in
water and neutralized by aqueous sodium carbonate solution
to get free base (2). It was ﬁltered, washed with water, dried
and recrystallized from ethanol and dioxane mixture to afford
white needles. Yield 65% (3.78 g).
A mixture of 2-(4-ﬂuorobenzyl)-6-(4-methoxyphenyl)imi-
dazo[2,1-b][1,3,4] thiadiazole (2) (2.19 g, 0.005 mol), morpho-
line (0.87 g, 0.01 mol), formalin (1 mL) and acetic acid
(1 mL) in methanol (20 mL) was reﬂuxed for 10 h (monitored
by TLC). Reaction mixture was diluted with water and ex-
tracted with chloroform (3 · 30 mL). The combined chloro-
form extract was washed with water (3 · 30 mL) and dried
over anhydrous sodium sulfate. The solvent was removed un-
der vacuum and the residue was recrystallized from benzene
and hexane mixture to afford yellow crystalline solid. Yield
85% (2.16 g).
2.3.1. 2-(4-Fluorobenzyl)-6-(4-methoxyphenyl)imidazo[2,1-b]-
[1,3,4] thiadiazole (2)
Yield 65%; m.p. 151–153 C; IR (KBr) m (cm1): 3010, 2834,
2812, 1610, 1509; 1H NMR [300 MHz, CDCl3]: d: 3.84 (s,
3H, OCH3), 4.26 (s, 2H, CH2), 6.93-7.74 (m, 8H, Ar-H),
7.88 (s, 1H, C5–H, imidazole). Anal. calcd. for C18H14FN3OS:S
N N
N
F
OMe
S
N N
N
F
OMe
N
O
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nol,reflux
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3
compounds 2 and 3.
Table 1 Crystal data and structure reﬁnement for (2).
Empirical formula C18 H14 F N3 O S
Formula weight 339.38
Temperature 293(2) K
Wavelength 0.71073 A˚
Crystal system, space group Monoclinic, P 21/n
Unit cell dimensions
a= 11.119(7) A˚
b= 5.667(4) A˚
c= 25.385(5) A˚
b= 91.185(13)
Volume 1599.1(14) A˚3
z 4
Calculated density 1.410 Mg/m3
Absorption coeﬃcient 0.223 mm1
F(000) 704
Crystal size 0.40 · 0.35 · 0.30 mm
Theta range for data collection 3.00–28.34
Limiting indices 14 6 h 6 14, 7 6 k 6 5,
33 6 l 6 28
Synthesis, spectroscopic and crystal structure analysis 213C, 63.71; H, 4.12; N, 12.38. Found: C, 63.74; H, 4.09; N,
12.41%, Mass m/z: 339 (m+).
2.3.2. 2-(4-Fluorobenzyl)-6-(4-methoxyphenyl)-5-morpholin-1-
ylmethyl-imidazo[2,1-b][1,3,4]thiadiazole (3)
Yield 85%; m.p. 135–137 C; IR (KBr) t (cm1): 3041, 2829,
2824, 1608, 1510; 1H NMR (300 MHz, CDCl3) d: 2.57 (t,
4H, C3, C5-H, morpholine), 3.73 (t, 4H, C2, C6-H,morpholine),
3.86 (s, 3H, OCH3), 3.90 (s, 2H, CH2N), 4.30 (s, 2H, CH2),
6.97–7.89 (m, 8H, Ar-H), Anal. calcd. for C23H23FN4O2S: C,
63.01; H, 5.25; N, 12.78. Found: C, 63.03; H, 5.21; N,
12.75%, Mass m/z: 438 (m+).
3. X-ray diffraction analysis
The X-ray diffraction data, for both compound (2) and com-
pound (3) were collected on a Bruker Smart CCD Area Detec-
tor System at I.I.Sc., Bangalore, using MoKa (0.71073 A˚)
radiation for the crystal. The data were reduced using SAINT-
PLUS (Bruker, 1998). The structure was solved by direct meth-
ods using SHELXS97 (Sheldrick, 1997) and difference Fourier
synthesis using SHELXL97 (Sheldrick, 1997). The positions
and anisotropic displacement parameters of all non-hydrogen
atoms were included in the full-matrix least-square reﬁnement
using SHELXL97 (Sheldrick, 1997)and the procedures were
carried out for a few cycles until convergence was reached.
The H atoms were placed at calculated positions in the riding
model approximation (C–H 0.93 A˚); their temperature factors
were set to 1.2 times those of the equivalent isotropic temper-
ature factors of the parent atoms. All other non-H atoms were
reﬁned anisotropically. Molecular diagrams were generated
using ORTEP (Farrugia, 1997). The mean plane calculation
was done using the program PARST (Nardelli, 1983).
3.1. Compound (2)
Intensity data were collected up to a maximum of 28.34 for the
compound in the x-scan mode. A total of 9702 reﬂections were
collected, resulting in 3910 independent reﬂections of which the
number of reﬂections satisfying I> 2 r(I) criteria were
1782. These were treated as observed. The R factor after ﬁnal
convergence was 0.0618 and the maximum and minimum val-
ues of residual electron density were 0.232 and 0.247 e A˚3.
3.2. Compound (3)
Intensity data were collected up to a maximum of 25.0 for the
compound in the x-scan mode. A total of 5430 reﬂections were
collected, resulting in 3631 independent reﬂections of which
the number of reﬂections satisfying I> 2 r(I) criteria were
2768. These were treated as observed. The R factor after ﬁnal
convergence was 0.0547 and the maximum and minimum val-
ues of residual electron density were 0.532 and 0.326 eA˚3.
Reﬂections collected/unique 9702/3910 [R(int) = 0.0623]
Completeness to theta 28.34 97.7%
Reﬁnement method Full-matrix least-squares on F2
Data/restraints/parameters 3910/0/218
Goodness-of-ﬁt on F2 0.968
Final R indices [I> 2sigma(I)] R1 = 0.0618, wR2 = 0.1487
R indices (all data) R1 = 0.1336, wR2 = 0.1945
Largest diﬀ. peak and hole 0.232 and 0.247 eA˚34. Results and discussion
4.1. Chemistry
The reaction of 2-(4-ﬂuorobenzyl)-6-(4-methoxyphenyl)imi-
dazo[2,1-b][1,3,4]thiadiazole (2) with p-methoxy-x-bromoace-tophenone is reﬂuxed in ethanol afforded the hydrobromide
salts of imdazole(2,1-b)1,3,4-thiadiazole which on basiﬁcation
with aqueous sodium carbonate solution gave the free base (2)
in good yield.
The structure of (2) was conﬁrmed by IR, NMR and mass
spectral data. The absence of vNH2 band in the IR Spectrum
and appearance of C5-H in the 1H NMR spectrum established
the formation of compound (2). The Mannich raeaction of (2)
with morpholine and formalin afforded compound (3). The
structure of (3) was established by its analytical and spectral
data. In the 1H NMR spectra the absence of peak around
7.88 ppm indicates that the proton at C-5 position of the imid-
azole group is not available. The protons corresponding to the
morpholine ring are indicated by the peaks at 2.57 and
3.73 ppm .These structures were further conﬁrmed by mass
spectral data and single crystal X-ray analysis. A number of
compounds containing 2-benzyl-6-phenyl-imidazo[2,1-
b][1,3,4] thiadiazole as the basic structural unit with various
substituents have been synthesized earlier and spectroscopi-
cally analyzed and reported (Badiger et al., 2009; Gupta
et al., 1993). Good quality single crystals suitable for crystallo-
graphic studies could be grown by slow evaporation technique
using ethanol and chloroform solvents for compounds (2) and
(3), respectively. In the present work we report the synthesis
and spectroscopic analysis of the two title compounds with
more emphasis laid on weak interactions.
4.2. Crystallography
The details of the crystal data and reﬁnements are given in Ta-
bles 1 and 2 for the compounds (2) and (3), respectively. The
selected bond distances and angles for compound (2) and (3)
Table 3 Selected bond lengths (A˚) and angles () for
compound (2).
S(1)–C(9) 1.723(3) C(9)–S(1)–C(10) 88.36(15)
S(1)–C(10) 1.760(3) C(9)–N(1)–C(7) 104.5(2)
N(1)–C(9) 1.312(3) C(10)–N(2)–N(3) 109.0(2)
N(1)–C(7) 1.391(3) C(9)–N(3)–C(8) 107.6(2)
N(2)–C(10) 1.291(4) C(9)–N(3)–N(2) 118.1(3)
N(2)–N(3) 1.365(3) C(8)–N(3)–N(2) 134.2(2)
N(3)–C(9) 1.361(3) C(1)–O(1)–C(18) 118.7(3)
N(3)–C(8) 1.365(4) C(8)–C(7)–N(1) 110.5(3)
F(1)–C(15) 1.355(4) N(1)–C(7)–C(4) 120.6(2)
O(1)–C(1) 1.371(4) N(3)–C(8)–C(7) 105.3(2)
O(1)–C(18) 1.422(4) N(1)–C(9)–N(3) 112.1(3)
C(7)–C(8) 1.369(3) N(1)–C(9)–S(1) 139.1(2)
C(10)–C(11) 1.487(4) N(3)–C(9)–S(1) 108.8(2)
N(2)–C(10)–S(1) 115.7(2)
C(11)–C(10)–S(1) 121.0(3)
Table 4 Selected bond lengths (A˚) and angles () for
compound (3).
S(1)–C(9) 1.727(3) C(1)–O(1)–C(23) 117.5(2)
S(1)–C(10) 1.770(3) C(20)–O(2)–C(21) 110.3(2)
F(1)–C(15) 1.364(3) C(10)–N(1)–N(2) 108.5(2)
O(1)–C(1) 1.372(3) C(9)–N(2)–N(1) 118.3(2)
O(1)–C(23) 1.416(4) N(1)–N(2)–C(8) 133.2(2)
O(2)–C(20) 1.424(3) C(9)–N(3)–C(7) 104.0(2)
O(2)–C(21) 1.428(4) C(18)–N(4)–C(19) 111.7(2)
N(1)–C(10) 1.295(3) O(1)–C(1)–C(2) 115.2(2)
N(1)–N(2) 1.373(3) O(1)–C(1)–C(6) 124.7(3)
N(2)–C(9) 1.361(3) C(8)–C(7)–N(3) 111.5(2)
N(2)–C(8) 1.386(3) N(3)–C(7)–C(4) 120.3(2)
N(3)–C(9) 1.314(4) N(2)–C(8)–C(7) 103.5(2)
N(3)–C(7) 1.401(3) N(2)–C(8)–C(18) 122.5(2)
N(4)–C(18) 1.462(3) N(3)–C(9)–N(2) 112.5(2)
N(4)–C(19) 1.462(3) N(3)–C(9)–S(1) 138.4(2)
N(4)–C(22) 1.470(3) N(2)–C(9)–S(1) 109.1(2)
C(8)–C(18) 1.492(4) N(1)–C(10)–C(11) 122.6(3)
C(10)–C(11) 1.491(4) N(1)–C(10)–S(1) 116.0(2)
C(11)–C(12) 1.514(4) C(11)–C(10)–S(1) 121.3(2)
C(12)–C(13) 1.385(4) C(16)–C(15)–F(1) 118.1(3)
C(19)–C(20) 1.514(4) F(1)–C(15)–C(14) 119.0(3)
C(21)–C(22) 1.507(4) N(4)–C(18)–C(8) 113.7(2)
N(4)–C(19)–C(20) 110.7(2)
O(2)–C(20)–C(19) 111.3(2)
Table 2 Crystal data and structure reﬁnement for (3).
Empirical formula C23 H23 F N4 O2 S
Formula weight 438.51
Temperature 293(2) K
Wavelength 0.71073 A˚
Crystal system, space group Triclinic, P-1
Unit cell dimensions
a= 7.4400(9) A˚
b= 10.5011(13) A˚
c= 14.2403(18) A˚
a= 88.108(2)
b= 80.189(2)
c= 72.735(2)
Volume 1046.7(2) A˚3
z 2
Calculated density 1.391 Mg/m3
Absorption coeﬃcient 0.192 mm1
F(000) 460
Crystal size 0.40 · 0.35 · 0.30 mm
Theta range for data collection 2.03 to 25.00 .
Limiting indices 8 6 h 6 7, 12 6 k 6 11,
16 6 l 6 16
Reﬂections collected/unique 5430/3631 [R(int) = 0.0244]
Completeness to theta 25.00% 98.3%
Reﬁnement method Full-matrix least-squares on F2
Data/restraints/parameters 3631/0/281
Goodness-of-ﬁt on F2 0.997
Final R indices [I> 2sigma(I)] R1 = 0.0547, wR2 = 0.1430
R indices (all data) R1 = 0.0731, wR2 = 0.1687
Largest diﬀ. peak and hole 0.532 and 0.326 eA˚3
Table 5 Non-bonded interactions and possible hydrogen
bonds (A˚, ) for compound (2) (D: donor; A: acceptor; H:
hydrogen).
D–H  A D–H H  A D  A D–H  A
C11–H11B. . .N1 0.970(3) 2.532(2) 3.456(4) 159 (4)
Symmetry code: x+ 1/2 + 1, +y  1/2, z+ 1/2.
Table 6 Non-bonded interactions and possible hydrogen
bonds (A˚, ) for compound (3) (D: donor; A: acceptor; H:
hydrogen).
D–H  A D–H H  A D  A D––H  A
C3–H3. . .N4 0.930(3) 2.523(2) 3.379(4) 153
C13–H13. . .O2i 0.930(3) 2.566(2) 3.407(3) 150
C11–H11A O2i 0.970(3) 2.664(2) 3.525(4) 148
C23–H23C. . .N3ii 0.960(3) 2.871(2) 3.471(4) 121
C17–H17. . .N3iii 0.930(3) 2.584(3) 3.457(4) 156
C19–H19B. . .F1iv 0.970(3) 2.666(2) 3.517(4) 146
Symmetry code: (0) x,y,z; (i) x+ 1,y,z+ 1; (ii)x+
2,y+ 1,z; (iii) x  1,+y,+z; (iv) x+ 1,+y  1,+z.
Figure 1 ORTEP diagram of compound (2), showing 50%
probability displacement ellipsoids and the atom-numbering
scheme.
214 A. Banu et al.are given in Tables 3 and 4, respectively. Tables 5 and 6 give
their respective hydrogen bond interactions. The ORTEP dia-
grams of the molecules 2 and 3 are shown in Figs. 1 and 2,
respectively. Figs. 3 and 4 show the hydrogen bond interac-
tions in crystal structure of (2) and (3), respectively.
Molecule (2) (Fig. 1) crystallizes in the monoclinic space
groupP21/n. The imidazo-thiadiazole andmethoxyphenyl rings
are coplanar with only 7.9 between them. Fluorobenzyl ring is
inclined at an angle of 68.8 to these two ring systems. Themeth-
oxy group is cis to imidazo-thiadiazole and benzene ring.
Molecule (3) (Fig. 2) crystallizes in the triclinic space group
P-1. The presence of morpholinomethyl ring decreases the pla-
Figure 2 ORTEP diagram of compound (3), showing 50% probability displacement ellipsoids and the atom-numbering scheme. Dotted
line indicates intramolecular C3–H3. . .N4 interaction.
Synthesis, spectroscopic and crystal structure analysis 215narity of the molecule. This can be seen in the angle between
imidazo-thiadiazole and methoxyphenyl rings increasing to
17.45 and that between ﬂuorobenzyl and imidazo-thiadiazole
increasing to 79.21. The morpholinomethyl ring is almost
orthogonal to imidazo-thiadiazole ring at an angle of 85.58.
A weak intramolecular C–H. . .N hydrogen bond interaction,
which forms an S(7) graph-set motif, helps to establish the
relative conformations of the ring systems involved. The mor-
pholinomethyl moiety adopts a conventional chair conforma-
tion with oxygen and nitrogen atoms deviating from the
plane and occupying apical and base positions respectively.
The bond lengths and angles in morpholinomethyl ring con-
form to standard values (Parkin et al., 2004).
In the crystal structure of (2), there are C–H. . .N interac-
tions (Fig. 3) (C11–H11B . . .N1) linking the molecules through
centrosymmetric dimers corresponding to the graph set (Bern-
stein et al., 1995) R22(12), along the crystallographic ‘c’ axis.Figure 3 Packing of the molecules in crystal of (2) viewed along
the ‘b’ axis. Dotted lines indicate C–H. . .N intermolecular
interactions resulting in dimers.Additionally there are F. . .F short contacts (3.081 A˚), provid-
ing cohesion. The aggregation is further reinforced by p–p
stacking interactions with the shortest distance being
3.502 A˚, between C16 and C18 atoms.
In the crystal structure of (3), there are C–H. . .O, C–H. . .N
and C–H. . .F interactions. The C–H. . .O interaction generates
a bifurcated bond from two donors, C11 and C13 to the same
acceptor, O2 connecting the molecules into chain along the ‘b’
axis (Fig. 4). Further, the C–H. . .N interactions also result in
bifurcated bond from two donors, C17 and C23 to the same
acceptor, N3 linking the dimers so formed into a tape pattern
along the ‘c’ axis (Fig. 5).
But the donor-acceptor distance is the least in the C–H. . .F
interaction (3.517 A˚) compared to those in C–H. . .O (3.525 A˚)
and C–H. . .N (3.457 A˚), this makes the C–H. . .F bond a
successful competitor for the C–H donor. This is unusual sinceFigure 4 Packing of the molecules of (3) with dotted lines
indicating C–H. . .O intermolecular interactions generating a
bifurcated bond along the ‘b’ axis.
Figure 5 View of the molecular packing in (3), showing C–H. . .N interactions along the ‘c’ axis.
Figure 6 Packing of the molecules of (3) with dotted lines
indicating C–H. . .F intermolecular interactions generating cyclic
dimers along the ‘b’ axis.
216 A. Banu et al.it happens in the presence of oxygen and nitrogen which are
strong acceptor atoms, thus making the C–H. . .F interaction
an important structure-directing entity. The molecules are
linked by paired C–H. . .F hydrogen bonds into cyclic dimers
corresponding to the graph set (Bernstein et al., 1995) notation
R22(28) (Fig. 6).
The molecular packing is further stabilized by p–p stacking
interactions between ﬂuorobenzyl rings with the shortest cen-
troid-centroid distance being 3.45 A˚ for C13–C13 carbons
[Cg–Cg symmetry code: x, 1  y, 1  z].
Notably, there are no F. . .F contacts, which shows that
ﬂuorine would form C–H. . .F interactions rather than F. . .F
contacts. This distinctly different behavior of F from other
heavier halogens that prefer halogen-halogen interactions has
been observed in many organo ﬂuorine compounds (Brock
et al., 1978; Weiss et al., 1997; Thalladi et al., 1998).
The presence of ﬂuorine atoms attached to the aromatic
ring increases the acidity of the aromatic hydrogen atoms as
is generally observed with aromatic compounds (Estarellaset al., 2008) and the strength of any C–H. . .X interaction
(X = halogen) depends on C–H group acidity. Regarding
the location of the F atom, the ﬂourobenzyl group is attached
to the thiadiazole part of imidazo-thiadiazole system. It is well
known that the imidazole and thiadiazole parts show different
p conjugations, owing to their fused nature. The imidazole
part of this imidazo-thiadiazole system is more resonance sta-
bilized. Additionally, the imidazo-thiadiazole entity is gener-
ally planar and rigid.
The crystal packing of compound (3) establishes the fact
that the so-called elusive C–H. . .F interaction can be as impor-
tant as C–H. . .O and C–H. . .N interactions in achieving a
cohesive self assembly. Supramolecular synthons based on this
weak interaction can be useful building blocks for construction
of crystalline superstructures. The prospects for such system-
atic design of structures are worth exploring.
5. Conclusion
This work describes the synthesis of an imidazo[2,1-b]-
[1,3,4]thiadiazole derivative and its subsequent aminomethyla-
tion in a Mannich reaction to give its corresponding 5-(mor-
pholinomethyl) derivative. Additionally, the X-ray analysis
was carried out in order to establish a supramolecular assem-
bly with the speciﬁc aim of assessing various weak interactions
including ﬂuorine interaction that control the architecture of
organic solids.Acknowledgments
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